LING, LEI,LINDHOUT, DARRIN, A. A,.琳霍特,雷.靈,達林.,.琳霍特
申请号:
HK14111250.6
公开号:
HK1198297A
申请日:
2014.11.06
申请国别(地区):
HK
年份:
2015
代理人:
摘要:
The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of fibroblast growth factor 19 (FGF19) and/or fibroblast growth factor 21 (FGF21), and variants or fusions of fibroblast growth factor 19 (FGF19) and/or fibroblast growth factor 21 (FGF21) proteins and peptide sequences (and peptidomimetics), having one or more activities, such as glucose lowering activity, and methods for and uses in treatment of hyperglycemia and other disorders.